Discover 1,955 paid clinical trials in Denton, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,955
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)
for
Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC),
Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer
for
Breast Cancer
Location: Dallas TX, San Antonio TX, Nashville TN, Salem VA,
Sponsor: SCRI Development Innovations, LLC
Sex: All
Age: 18+
Code: NCT05748834
Phase 2, Recruiting
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
for
Non-small Cell Lung Cancer (NSCLC)
Location: Dallas TX, Lincoln NE, Nashville TN, Atlanta GA,
Sponsor: Genmab
Sex: All
Age: 18+
Code: NCT07288177
Phase 2, Recruiting
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
for
Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Location: Plano TX, Dallas TX, Austin TX, Houston TX,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 18+
Code: NCT07207811
Phase 3, Recruiting
KRT-232 and TKI Study in Chronic Myeloid Leukemia
for
Chronic Myeloid Leukemia
Location: Dallas TX, Birmingham AL, Milwaukee WI, Augusta GA,
Sponsor: Kartos Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT04835584
Phase 1, Phase 2, Recruiting
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
for
Chronic Obstructive Pulmonary Disease
Location: Carrollton TX, Allen TX, Dallas TX, DeSoto TX,
Sponsor: Sanofi
Sex: All
Age: 40 - 70+
Code: NCT07190209
Phase 3, Recruiting
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Tesetaxel as First-line Therapy for Metastatic Breast Cancer
for
Breast Neoplasm
Location: Dallas TX, Greensboro NC, New York NY
Sponsor: Genta Incorporated
Sex: Female
Age: 18+
Code: NCT01221870
Phase 2, Recruiting
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
for
Hormone Receptor Positive HER-2 Negative Breast Cancer,
Location: Dallas TX, Springfield MO, Kansas City MO, Columbia MO,
Sponsor: Puma Biotechnology, Inc.
Sex: All
Age: 18+
Code: NCT06369285
Phase 2, Recruiting
Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention
for
HIV Infections
Location: Dallas TX, Houston TX, Kansas City MO, New Orleans LA,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT07473778
Recruiting
Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy
for
HIV Infections
Location: Dallas TX, Kansas City MO, Atlanta GA, Savannah GA,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT07682961
Phase 3, Recruiting
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial